RxDoctor Payments Data

Joseph Toney, DO

Family Medicine · Piedmont, MONPI 1649587031

Payments from drug & device makers

$853in general payments, 2019–2025

Across 45 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braeburn Inc.$241
  • Johnson & Johnson$151
  • Indivior Inc.$92
  • AbbVie$48
  • Lilly USA, LLC$43
  • Grifols USA, LLC$38
  • plus $239 from 12 others

What the payments were for

  • Food & beverage$81896%
  • Education$354%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$853 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$8,214
Medicare patients
149
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl279$40,226
SublocadeBuprenorphine17$34,756
Spiriva HandihalerTiotropium Bromide31$18,400
TrulicityDulaglutide18$17,253
MounjaroTirzepatide15$16,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,495
BrixadiBuprenorphine12$11,630
FarxigaDapagliflozin Propanediol17$9,706
JardianceEmpagliflozin12$9,702
SuboxoneBuprenorphine Hcl/Naloxone Hcl24$8,890
LinzessLinaclotide14$7,550
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$6,792
BrilintaTicagrelor12$5,324
SymbicortBudesonide/Formoterol Fumarate18$4,006
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$3,464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Sublocade, Suboxone$92$43,64641 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl$35$41,965301 claims
Lilly USA, LLCTrulicity, Mounjaro, Olanzapine$43$33,56248 claims
GSKTrelegy Ellipta, Anoro Ellipta$13$19,28735 claims
Braeburn Inc.Brixadi$241$11,63012 claims
AbbVieLinzess, Synthroid$48$8,15327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Piedmont

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →